Assessing Social Determinants of Health with Data-Driven Approach to Identify and Address Risk Exposure with Ashley Perry Socially Determined TRANSCRIPT
Download PDFApr 27, 2023
Ashley Perry is the Chief Strategy and Solutions Officer at Socially Determined, a social risk analytics and solutions company working with payers, providers, and life science companies. Their Socialscope risk and data analytics platform helps organizations understand social determinants of health, identify and manage...
Apr 27, 2023
Ashley Perry is the Chief Strategy and Solutions Officer at Socially Determined, a social risk analytics and solutions company working with payers, providers, and life science companies. Their Socialscope risk and data analytics platform helps organizations understand social determinants of health, identify and manage...
Path to Bringing Prodrugs to Market for Rare Diseases with Rich Pascoe Zevra Therapeutics TRANSCRIPT
Download PDFApr 26, 2023
Rich Pascoe, CEO of Zevra Therapeutics, is working with a team with deep experience developing drugs and getting them approved by the FDA. Having developed multiple prodrugs for pain and ADHD, Zevra is now developing rare disease therapies with an initial focus on Niemann Pick Disease Type C and...
Apr 26, 2023
Rich Pascoe, CEO of Zevra Therapeutics, is working with a team with deep experience developing drugs and getting them approved by the FDA. Having developed multiple prodrugs for pain and ADHD, Zevra is now developing rare disease therapies with an initial focus on Niemann Pick Disease Type C and...
Advanced RNA Technology Cost-Effectively Creating mRNA Vaccines for Viruses and Cancer with Steven Reed HDT Bio TRANSCRIPT
Download PDFApr 25, 2023
Steve Reed, Co-Founder, President, and CEO of HDT Bio, has spent his life focusing on tropical diseases and points out how the cost of developing and manufacturing vaccines determines access for a global population. HDT Bio was founded to develop more cost-effective technology to induce broader immune responses to...